Antibody drug conjugates (ADCs): an expanding rational treatment paradigm in breast cancer
نویسندگان
چکیده
Recent advances in bioengineering and manufacturing have catapulted Antibody–drug conjugates (ADCs) to broader clinical applications. ADCs take advantage of the exquisite specificity monoclonal antibodies (mAb) deliver a highly potent cytotoxic agent specifically targeted cell expressing selected antigen. HER2-positive breast cancer has served as testing ground for ADC development solid tumors that over-express HER2/neu by linking trastuzumab payload agent. With current advances, leverage selective targeting agents which otherwise narrow therapeutic index. Ado-trastuzumab emtansine (T-DM1) was first approved patients with HER2-postive metastatic (MBC) fam-trastuzumab deruxtecan-nxki (T-DXd) recently well. Sacituzumab govitecan-hziy (SG) 2020 triple negative (TNBC). Studies focusing on utilizing earlier stages neoadjuvant or adjuvant setting, central nervous system (CNS) disease are progress. New bispecific (bAbs) also development.
منابع مشابه
Methods to Design and Synthesize Antibody-Drug Conjugates (ADCs).
Antibody-drug conjugates (ADCs) have become a promising targeted therapy strategy that combines the specificity, favorable pharmacokinetics and biodistributions of antibodies with the destructive potential of highly potent drugs. One of the biggest challenges in the development of ADCs is the application of suitable linkers for conjugating drugs to antibodies. Recently, the design and synthesis...
متن کاملFrom Anthramycin to Pyrrolobenzodiazepine (PBD)‐Containing Antibody–Drug Conjugates (ADCs)
The pyrrolo[2,1-c][1,4]benzodiazepines (PBDs) are a family of sequence-selective DNA minor-groove binding agents that form a covalent aminal bond between their C11-position and the C2-NH2 groups of guanine bases. The first example of a PBD monomer, the natural product anthramycin, was discovered in the 1960s, and the best known PBD dimer, SJG-136 (also known as SG2000, NSC 694501 or BN2629), wa...
متن کاملDrug Conjugates Such as Antibody Drug Conjugates (ADCs), Immunotoxins and Immunoliposomes Challenge Daily Clinical Practice
Drug conjugates have been studied extensively in preclinical in vitro and in vivo models but to date only a few compounds have progressed to the clinical setting. This situation is now changing with the publication of studies demonstrating a significant impact on clinical practice and highlighting the potential of this new class of targeted therapies. This review summarizes the pharmacological ...
متن کاملMeasuring Drug-to-Antibody Ratio (DAR) for Antibody-Drug Conjugates (ADCs) with UHPLC/Q-TOF
In this paper, we are investigating an antibody drug conjugate (ADC) with a cysteine linker. The Agilent 1290 Infinity II liquid chromatography system connected to a PLRP-S reversed phase liquid chromatography column was used to separate restored light and heavy chains and light and heavy chains of the corresponding drug linkers. Each chromatographic peak was verified through the Agilent 6530 H...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International journal of cancer care and delivery
سال: 2022
ISSN: ['2770-3533']
DOI: https://doi.org/10.53876/001c.33661